propionylcarnitine has been researched along with Diabetic Angiopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabriella, C; Gea, OC; Giuseppe, M; Giuseppe, P; Luigi, DP; Margherita, F; Massimiliano, A; Roberto, F; Santo, SS; Sergio, N | 1 |
| Barone, G; Costanza, G; Di Salvo, A; Marchese, G; Verruso, G; Zamueli, M | 1 |
| Coto, V; D'Alessandro, L; Grattarola, G; Imparato, L; Lingetti, M; Mancini, M; Nolfe, G; Rengo, F | 1 |
| Bianchi, M; Ghirlanda, G; Greco, AV; Mingrone, G | 1 |
4 trial(s) available for propionylcarnitine and Diabetic Angiopathies
| Article | Year |
|---|---|
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD.
Topics: Aged; Aldehydes; Ankle; Blood Glucose; Blood Pressure; Brachial Artery; Carnitine; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Glycated Hemoglobin; Humans; Malondialdehyde; Middle Aged; Oxidation-Reduction; Pain Measurement; Placebos | 2006 |
[Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
Topics: Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Diabetic Angiopathies; Female; Humans; Leg; Male; Middle Aged | 1999 |
Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Carnitine; Diabetic Angiopathies; Female; Humans; Intermittent Claudication; Male; Middle Aged; Patient Compliance; Regression Analysis; Stereoisomerism | 1992 |
Effect of propionyl-L-carnitine in the treatment of diabetic angiopathy: controlled double blind trial versus placebo.
Topics: Administration, Oral; Aged; Analysis of Variance; Carnitine; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Ultrasonography; Walking | 1992 |